Welcome!

News Feed Item

Lateral Flow Technology And The Future Of Point Of Care Diagnostics, 2nd Edition

LONDON, March 11, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Lateral Flow Technology And The Future Of Point Of Care Diagnostics, 2nd Edition

Lateral flow (LF) tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point-of-care testing, looking at both self-testing by patients and at point-of-care testing by healthcare professionals.

Lateral flow devices and tests have been a popular platform for rapid immunoassays since their introduction in the mid-1980s, and since our last look at the market there has been continued interest and innovations. This report profiles over a hundred companies that currently market lateral flow tests. Many of these companies, plus more than ten additional companies, are developing innovations in lateral flow-based devices. Companies profiled in this report use lateral flow technology to develop and market a wide range of rapid tests for market segments of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.

Every critical aspect of the lateral flow test market is addressed, including the following key topics:

• The current sales figures for LF productsand realistic projections for 2017
• The core factors driving LF testing revenues up.
• Breakout of LF-POC market by Self Test and Professional Breakout of LF-POC market by Key Test Segments (Fertility, Infectious Disease, Cardiac Markers, Oncology, Drugs of Abuse, Other)
• The trends to watch that could increase sales predictions.
• Need-to-know companies in Lateral Flow Test devices.
• Expected gains to be made by LF POC devices over lab-based immunoassays across categories.
• Regional markets for lateral flow tests (US, Europe, Japan, ROW)
• Obstacles that could trap new entrants.

Growth in lateral flow point-of-care testing is being fueled by many factors fueling growth of the point-of-care market as a whole. These include the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, cancer and other chronic conditions, and many other factors. Decentralized testing and the ability to get rapid test results is emerging as a tool for more efficient diagnosis and patient evaluation, and to improve the quality of patient care.

This report provides a realistic assessment acknowledging the reality of payors' emphasis on cost/benefit analysis for new technologies. Current sales and predictions for 2017 sales are provided for the diabetes, oncology, cardiac marker, pregnancy and other LF test markets.

Kalorama's unique and thorough research process provides an exhaustive analysis of this evolving market. Information was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.

CHAPTER ONE: EXECUTIVE SUMMARY
Overview
Scope and Methodology
Market Overview

CHAPTER TWO: INTRODUCTION
Background – PointofCare and Rapid Testing
Overview of Lateral Flow Devices
Point of View

CHAPTER THREE: TECHNICAL ISSUES AND INNOVATIONS FOR LATERAL FLOW DEVICES
Technical Issues and Hurdles with Lateral Flow Devices
Alternate Test Samples
Automating Reading of Lateral Flow Test Results
Connectivity
Innovations with Lateral Flow Devices
Lateral Flow in Molecular Diagnostics [Nucleic Acid Lateral Flow]
Emerging Technologies Competing Against Lateral Flow

CHAPTER FOUR: ISSUES AND TRENDS
Patent focused drivers
Medical/Healthcare related drivers
Technology drivers
Economic drivers
Other drivers
Advantages and Disadvantages of Lateral Flow POC Testing

Advantages:
Disadvantages:



CHAPTER FIVE: MARKET ANALYSIS
Market Overview
Current Markets and Market Forecasts –
Lateral Flow PointofCare Testing

Self Testing/OTC
Professional Lateral Flow PointofCare Testing

Lateral Flow POC Testing and Rapid Testing in World Markets

The United States
Europe
Rest of World


Market Segments by Test Category

Fertility (Pregnancy, Ovulation, and Menopause)
Infectious Disease

HIV POC Testing
Influenza
Tuberculosis


Cardiac Markers
Oncology Markers
Drugs of Abuse and Alcohol
Other Lateral Flow PointofCare Tests

Locations for Lateral Flow PointofCare Testing

CHAPTER SIX: COMPANIES MARKETING LF POC/RAPID TEST DEVICES
1 Step Detect Associates, LLC
Access Bio, Inc.
AccuBioTech Co., Ltd.
Accumed Biology (Shanghai) Co., Ltd.
Accutech, LLC
Alere Inc.

Recent Revenue History:


Amedica Biotech
American Bio Medica Corporation

Recent Revenue History:
Company Overview and POC Products:

Apacor Ltd.
Artron Laboratories Inc.
Atlas Link Biotech Co., Ltd.
Augurix SA/Augurix Diagnostics
Autobio Diagnostics Co., Ltd.
AZOG, Inc.
BD (Becton Dickinson)

Recent Revenue History:
Company Overview and POC Products:


Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)

Recent Revenue History:
Company Overview and POC Products:


Biocare Diagnostics Ltd.
Biomerica, Inc.

Recent Revenue History
Company Overview and POC Products

bioMérieux sa

Recent Revenue History
Company Overview and POC Products:
Recent Revenue History
Company Overview and POC Products


BioScan Screening Systems, Inc
BioSino BioTechnology and Science Inc.
Blue Cross Biomedical Co., Ltd.
BNTX Inc
Boson Biotech Co., Ltd.
Branan Medical Corporation
BÜHLMANN Laboratories AG
Calypte Biomedical Corporation

Recent Revenue History
Company Overview and POC Products
Recent Revenue History

Company Overview and POC Products


Dr. Fooke Laboratorien GmbH
DRG International, Inc.

Recent Revenue History


Embryotech Laboratories
Enterix Inc. (A Quest Diagnostics Company)
Eurospital Spa
Express Diagnostics International
EY Laboratories, Inc.
First Check Diagnostics Corp. (Subsidiary of Alere)
First Diagnostic LLC
GenBio
Germaine Laboratories
Healgen Scientific LLC
Hema Diagnostic Systems, LLC (HDS)

Hemosure, Inc.
Hightop Biotech Co., Ltd.
IDenta Corporation
ImmunoMycologics, Inc.
ImmunoScience, Inc.
Immunostics, Inc
InBios International, Inc.
Instant Technologies, Inc.
InTec Products, Inc.
International ImmunoDiagnostics
Jant Pharmacal Corporation
Jei Daniel Biotech Corp.
Labsystems Diagnostics Group (Formerly Ani Biotech Oy)
Labtest
LifeSign LLC
Liming BioProducts Co., Ltd.
MagnaBioSciences, LLC
MAVAND Solutions GmbH
Medisensor, Inc.
Mediwatch Plc

Medix Biochemica
MedMira Inc.

Recent Revenue History
Company Overview and POC Products
Recent Revenue History
Company Overview and POC Products
Recent Revenue History
Company Overview and POC Products


Polymed Therapeutics, Inc.
Precheck Bio, Inc.
Prestige Diagnostics
Preventis GmbH
Princeton Biomeditech Corporation
Quidel Corporation

Recent Revenue History
Company Overview and POC Products



RBiopharm AG
Real World Diagnostics
Redwood Toxicology Laboratory, Inc.
ReLIA Diagnostics, Inc.
RENESA UG

Recent Revenue History
Company Overview and POC Products


Reszon Diagnostics International Sdn. Bhd.
SA Scientific
Savyon Diagnostics
Screening Devices Canada, Inc.
Sekisui Medical Co., Ltd.
Serascience
Sichuan Maker Biotechnology Co., Ltd.
Standard Diagnostics (Part of Alere)
SureScreen Diagnostics
Syntron Bioresearch, Inc.
Systagenix Wound Management
TECHLAB, Inc.
Teco Diagnostics
Theradiag
Trinity Biotech plc

Recent Revenue History
Company Overview and POC Products


Turklab Medical Devices Inc.
UCP Biosciences, Inc.
US Diagnostics, Inc.
VEDA.LAB SA
Viricell S.L.
WAMA Diagnostica
Zhuhai Encode Medical Engineering Co., Ltd.

CHAPTER SEVEN: COMPANIES ENTERING LF POC/RAPID TEST MARKET OR LAUNCHING NOVEL TESTS
Alverix, Inc.
Arbor Vita Corporation
Axxin
BioAMD Ltd.
BioMedomics
Corgenix Medical Corporation
Epinex Diagnostics, Inc.
Genisphere, LLC
GenPrime, Inc.
Mesa Tech International, Inc.
TwistDx, Ltd.
Venaxis, Inc. (Formerly Aspen BioPharma, Inc.)
LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY
Table 11: Lateral Flow Rapid Test Sales, Worldwide, 2012 and 2017

CHAPTER THREE: TECHNICAL ISSUES AND INNOVATIONS FOR LATERAL FLOW DEVICES
Table 31: Selected Companies with Saliva or OralFluid Collection Devices
Table 32: Selected Companies With Readers for Lateral Flow Devices
Table 33: Selected Companies Developing and/or Marketing Innovations in LFT
Table 34: Selected Companies Using Lateral Flow in Molecular Diagnostics
Table 35: Selected Companies Developing and/or Marketing POC Diagnostic Platforms that May Compete with Lateral Flow Immunoassays

CHAPTER FOUR: ISSUES AND TRENDS
Table 41: Selected Companies Outside of North America, Europe, or Japan Marketing Lateral Flow Diagnostic Tests

CHAPTER FIVE: MARKET ANALYSIS
Table 51: Lateral Flow OTC/SelfTest Sales by Test Category, Worldwide, 2012 and 2017 (Fertility, Infectious Disease, Cardiac Markers, Oncology, Drugs of Abuse, Other)
Table 52: Lateral Flow Professional POC/Rapid Test Sales by Test Category, Worldwide, 2012 and 2017 (Fertility, Infectious Disease, Cardiac Markers, Oncology, Drugs of Abuse, Other)
Table 53: PointofCare Test Sales by Region, 2012 and 2017 (All POC Tests)
Table 54: Worldwide POC/Rapid Test Sales by Test Category, 2012 and 2017 (Fertility, Infectious Disease, Cardiac Markers, Oncology, Drugs of Abuse, Other)
Table 55: Selected Companies Marketing Fertility LFBased Tests
Table 56: Selected Companies Marketing Infectious Disease LFBased Tests
Table 57: Selected Companies Marketing LFBased Cardiac Marker Tests
Table 58: Selected Companies Marketing LF Oncology LFBased Tests
Table 59: Selected Companies Marketing Drugs of Abuse LFBased Tests
Table 510: Selected Companies Marketing Other LFBased Tests

Read the full report:
Lateral Flow Technology And The Future Of Point Of Care Diagnostics, 2nd Edition
http://www.reportbuyer.com/pharma_healthcare/diagnostics/lateral_flow_technology_future_point_care_diagnostics_2nd_edition.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, we provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Containers and Kubernetes allow for code portability across on-premise VMs, bare metal, or multiple cloud provider environments. Yet, despite this portability promise, developers may include configuration and application definitions that constrain or even eliminate application portability. In this session we'll describe best practices for "configuration as code" in a Kubernetes environment. We will demonstrate how a properly constructed containerized app can be deployed to both Amazon and Azure ...
If a machine can invent, does this mean the end of the patent system as we know it? The patent system, both in the US and Europe, allows companies to protect their inventions and helps foster innovation. However, Artificial Intelligence (AI) could be set to disrupt the patent system as we know it. This talk will examine how AI may change the patent landscape in the years to come. Furthermore, ways in which companies can best protect their AI related inventions will be examined from both a US and...
The challenges of aggregating data from consumer-oriented devices, such as wearable technologies and smart thermostats, are fairly well-understood. However, there are a new set of challenges for IoT devices that generate megabytes or gigabytes of data per second. Certainly, the infrastructure will have to change, as those volumes of data will likely overwhelm the available bandwidth for aggregating the data into a central repository. Ochandarena discusses a whole new way to think about your next...
Charles Araujo is an industry analyst, internationally recognized authority on the Digital Enterprise and author of The Quantum Age of IT: Why Everything You Know About IT is About to Change. As Principal Analyst with Intellyx, he writes, speaks and advises organizations on how to navigate through this time of disruption. He is also the founder of The Institute for Digital Transformation and a sought after keynote speaker. He has been a regular contributor to both InformationWeek and CIO Insight...
Behera Rasananda is a technologist, a leader, a key note speaker has more than 20 years experience in across Government, Financial, Heath Care and Insurance Verticals. Mr. Behera has vast experience in Enterprise Cloud and Big Data solutions and Enterprise Architecture. Currently he works closely for Government Solutions on Enterprise Cloud for Federal Government Agency. Scientist Behera managed and partner with clients to make complete end to end solution and Migration to cloud both private sec...
All zSystem customers have a significant new business opportunity to extend their reach to new customers and markets with new applications and services, and to improve the experience of existing customers. This can be achieved by exposing existing z assets (which have been developed over time) as APIs for accessing Systems of Record, while leveraging mobile and cloud capabilities with new Systems of Engagement applications. In this session, we will explore business drivers with new Node.js apps ...
In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices.
Cloud applications are seeing a deluge of requests to support the exploding advanced analytics market. “Open analytics” is the emerging strategy to deliver that data through an open data access layer, in the cloud, to be directly consumed by external analytics tools and popular programming languages. An increasing number of data engineers and data scientists use a variety of platforms and advanced analytics languages such as SAS, R, Python and Java, as well as frameworks such as Hadoop and Spark...
The now mainstream platform changes stemming from the first Internet boom brought many changes but didn’t really change the basic relationship between servers and the applications running on them. In fact, that was sort of the point. In his session at 18th Cloud Expo, Gordon Haff, senior cloud strategy marketing and evangelism manager at Red Hat, will discuss how today’s workloads require a new model and a new platform for development and execution. The platform must handle a wide range of rec...
The technologies behind big data and cloud computing are converging quickly, offering businesses new capabilities for fast, easy, wide-ranging access to data. However, to capitalize on the cost-efficiencies and time-to-value opportunities of analytics in the cloud, big data and cloud technologies must be integrated and managed properly. Pythian's Director of Big Data and Data Science, Danil Zburivsky will explore: The main technology components and best practices being deployed to take advantage...
Bill Schmarzo, Tech Chair of "Big Data | Analytics" of upcoming CloudEXPO | DXWorldEXPO New York (November 12-13, 2018, New York City) today announced the outline and schedule of the track. "The track has been designed in experience/degree order," said Schmarzo. "So, that folks who attend the entire track can leave the conference with some of the skills necessary to get their work done when they get back to their offices. It actually ties back to some work that I'm doing at the University of ...
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
Enterprises are universally struggling to understand where the new tools and methodologies of DevOps fit into their organizations, and are universally making the same mistakes. These mistakes are not unavoidable, and in fact, avoiding them gifts an organization with sustained competitive advantage, just like it did for Japanese Manufacturing Post WWII.